Cybin inc. announces appointment of aaron bartlone as chief operating officer

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce the appointment of aaron bartlone as chief operating officer of cybin inc., effective july 1, 2023. mr. bartlone has served as chief operating officer of cybin's u.s. subsidiary, cybin us holdings, inc., since march 202.
CYBN Ratings Summary
CYBN Quant Ranking